Clinical trial

Prevalence and Determinants of Obesity in PKU Patients

Invitation only · Not applicable · 1 countries · Registry ID NCT07703020

Invitation onlyNot applicableObservational

What this study is about

This observational cross-sectional multicenter study aims to assess the prevalence of overweight and obesity in adult patients with phenylketonuria (PKU) and to identify associated risk factors. Adult PKU patients followed in metabolic centers in Switzerland and Austria will be evaluated using clinical data, laboratory parameters, and standardized questionnaires addressing diet, physical activity, and psychological factors. The study seeks to better understand contributors to weight gain in this population to inform preventive strategies.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed
SexAll
Healthy volunteersNot accepted
ConditionPhenylketonuria (PKU)

Full registry criteria

Inclusion Criteria: * Confirmed diagnosis of phenylketonuria (PKU) by biochemical and/or molecular testing. * Age ≥ 18 years. * Ability to provide written informed consent. Exclusion Criteria: * Pregnant or lactating women. * Inability to follow the study procedures (e.g., due to language barriers). * Eligible participants who refuse to be informed of any important health concern discovered during the study. * Investigators, their family members, employees, or anyone with a personal link to the investigator other than a doctor-patient relationship.

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Prevalence of overweight and obesity in adult PKU patientsAt enrollment

Defined according to WHO BMI categories (overweight: 25.0-29.9 kg/m²; obesity class I-III: ≥30.0 kg/m²)

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Lausanne University Hospital🇨🇭 Lausanne, Canton of Vaud, Switzerland